Welcome to your Daily Dose of Health Tech Innovation!
Stay ahead with the latest breakthroughs revolutionizing healthcare—from AI diagnostics to remote care solutions.
We bring you expert-curated insights, emerging trends, and must-know updates from the digital health frontier.
Whether you’re a clinician, innovator, or health tech enthusiast, this roundup delivers what matters most.
Let’s dive into the future of health, one innovation at a time.
AstraZeneca Acquires Modella AI to Boost Oncology R&D
Modella AI, a leader in artificial intelligence for life sciences, announced that it has been acquired by AstraZeneca, expanding the companies’ existing collaboration to advance the application of multi-modal AI foundation models and AI agents across AstraZeneca’s global oncology portfolio.
The acquisition follows a multi-year agreement with AstraZeneca announced in July 2025 and will integrate Modella AI’s generative and agentic AI platform into AstraZeneca’s oncology research and development organization, supporting efforts to accelerate clinical development, enhance biomarker discovery, and enable the next wave of data-driven decision-making across the pipeline.
MOBE Partners with Sidekick Health to Expand Chronic Care
Chronic diseases are the leading cause of illness, disability and death in America, and more than 75% of U.S. adults now manage one or more chronic conditions, totaling over 90% of the entire annual health care spend in the country. To better support these individuals—and help health plans and employers improve outcomes and control rising costs—MOBE today announced a partnership and strategic investment in Sidekick Health, a leading digital platform for multi-condition and medication support. The partnership will expand MOBE’s whole-person model and enhance its delivery of personalized, clinically supported condition management for populations with Multiple Chronic Conditions (MCC).
Hippocratic AI Expands into Healthcare with Generative AI
Hippocratic AI, the global leader and pioneer in generative AI healthcare agents, announced details of its recent period of transformative growth across all major healthcare verticals following its Series C, which raised $126 million at a $3.5 billion valuation in November. This continued strong momentum includes new partnerships with health systems, new and deepened engagement with national payors, an expanded presence in the public sector, and strategic scale-up in the life sciences division. Coupled with over 150 million clinical interactions made to date, these developments underscore the company’s mission to bring healthcare abundance through safe, scalable, and patient-focused generative AI healthcare agents.
Bayer Accelerates Pharma Growth on High-Value Portfolio
On the occasion of the 44th J.P. Morgan Healthcare Conference in San Francisco, Bayer AG unveiled the strategic focus for its Pharmaceuticals Division in 2026.
Capitalizing on new launch momentum, the company will drive significant global regulatory expansions and market penetration across its pharmaceutical portfolio. High-value commercial products and an accelerating modality-rich pipeline across oncology, cardiology, neurology, and immunology have firmly cemented the Pharmaceuticals Division’s growth for the coming years. Five pivotal worldwide approvals in 2025 underscore a landmark year of strategic execution, validating the successful advancement of Bayer’s ambitious pharmaceutical growth strategy.
SOLIS MAMMOGRAPHY ACQUIRES WOMEN’S CENTER FOR RADIOLOGY
Solis Mammography, the largest independent provider of specialized breast health services in the United States, has acquired Women’s Center for Radiology, marking its entry into the Orlando market and expanding its presence across Florida. With nine existing locations in Gainesville, Fort Lauderdale, and Miami, Solis Mammography aims to bring its decades-long commitment to early detection and personalized breast care to a new community. Women’s Center for Radiology operates two centers in Orlando and has a long history of providing comprehensive breast health services, including being the first in Florida to offer 3D mammography. The acquisition aligns with Solis Mammography’s mission of early detection and delivering compassionate, patient-focused care.
To share your insights, please write to us at sudipto@intentamplify.com
